Stay updated on NICHE: Clinical Trial on IO in Early Colon Cancer
Sign up to get notified when there's something new on the NICHE: Clinical Trial on IO in Early Colon Cancer page.

Latest updates to the NICHE: Clinical Trial on IO in Early Colon Cancer page
- Check3 days agoChange DetectedRevision label updated to v3.5.5, indicating a new build of the page. This update reflects an administrative version bump rather than changes to the study data or displayed content.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a new build/version of the page.SummaryDifference0.0%

- Check47 days agoChange DetectedThis reflects a minor ClinicalTrials.gov frontend/system revision update, changing the displayed version marker without modifying the study details shown on the page.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check97 days agoChange DetectedAccrual for cohort 8 was reached in February 2026. As of February 2026, only cohorts 5 and 7 remain open for recruitment, and patients with dMMR/MSI tumors will be automatically registered in cohort 7 to receive nivolumab + relatlimab.SummaryDifference0.3%

Stay in the know with updates to NICHE: Clinical Trial on IO in Early Colon Cancer
Enter your email address, and we'll notify you when there's something new on the NICHE: Clinical Trial on IO in Early Colon Cancer page.